BioSpace News Archive

Drug Development

Novartis Spinout resTORbio Hits Endpoints on Phase II Trial of Respiratory Infections

Boston-based resTORbio, which was spun out of Novartis in April 2017, announced positive topline results from its Phase IIb clinical trial of RTB101 in patients with respiratory tract infections (RTIs).

July 25, 2018
·
3 min read
·
Mark Terry
Drug Development

Nabriva Acquires Zavante Therapeutics and its Late-Stage Antibiotic

Shares of Nabriva Therapeutics are rising this morning after the company announced it acquired privately-held Zavante Therapeutics.

July 25, 2018
·
2 min read
·
Alex Keown
Drug Development

Takeda’s Alunbrig Shows Superiority Over Pfizer’s Xalkori in Some Lung Cancer Patients

Takeda Pharmaceutical’s Alunbrig (brigatinib) hit its Phase III primary endpoints of statistically significant improvement in progression-free survival compared to crizotinib (Pfizer’s Xalkori) in a subset of lung cancer patients following the first pre-specified interim analysis.

July 25, 2018
·
2 min read
·
Alex Keown
Policy

Updated: U.S. House Votes to Repeal Medical Device Tax, Goes Before Senate

After multiple suspensions, the U.S. House of Representatives overwhelmingly voted to repeal a 2.3 percent tax on medical devices that was part of the Affordable Care Act that industry representatives believed stifled innovation.

July 25, 2018
·
2 min read
·
Alex Keown